General
Preferred name
MULBERROSIDE A
Synonyms
FM74212 ()
P&D ID
PD011951
CAS
102841-42-9
Tags
available
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Mulberroside A treatment could down-regulate P-gp expression and function accompanied by the activation of PKC and NF-κB, and this should be taken into consideration in potential herb-drug interactions when Mulberroside A or M. alba are co-administered with other drugs transported by P-gp. (BOC Sciences Bioactive Compounds)
Compound Sets
4
BOC Sciences Bioactive Compounds
mulberroside-a-cas-102841-42-9-item-159132
Cayman Chemical Bioactives
27545
MedChem Express Bioactive Compound Library
HY-N0619
Selleckchem Bioactive Compound Library
mulberroside-a
External IDs
21
Properties
(calculated by RDKit )
Molecular Weight
568.18
Hydrogen Bond Acceptors
14
Hydrogen Bond Donors
10
Rotatable Bonds
8
Ring Count
4
Aromatic Ring Count
2
cLogP
-2.37
TPSA
239.22
Fraction CSP3
0.46
Chiral centers
10.0
Largest ring
6.0
QED
0.15
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
Apoptosis
Immunology/Inflammation
Metabolic Enzyme/Protease
Target
Interleukin Related
TNF Receptor
Tyrosinase
Caspase,ERK,Interleukins,JNK,NF-??,p38 MAPK,TNF-alpha
Solubility
DMSO: 40 mg/mL
Source data